The U.S. CDC has changed the recommended dosage of HPV vaccines for 11-to 12-year-olds from three to two.
The CDC now recommends that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart. Adolescents aged 13 and 14 can also receive the two-dose schedule, but teens and young adults who start the series later, at ages 15 through 26 years, will continue to need three doses, the agency said.
Merck's Gardasil and GlaxoSmithKline's Cervarix vaccines have been available for years, but acceptance by the public has been slow.
In fact, last week, FiercePharma reported that GSK has decided to pull out of the U.S. market with its HPV vaccine Cervarix, after facing low market demand.
Read the Business Insider coverage